264 related articles for article (PubMed ID: 30609162)
1. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
[TBL] [Abstract][Full Text] [Related]
2. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
[TBL] [Abstract][Full Text] [Related]
3. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
[TBL] [Abstract][Full Text] [Related]
5. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
[TBL] [Abstract][Full Text] [Related]
6. Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change.
Kling CE; Perkins JD; Landis CS; Limaye AP; Sibulesky L
Am J Transplant; 2017 Nov; 17(11):2863-2868. PubMed ID: 28688205
[TBL] [Abstract][Full Text] [Related]
7. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
[TBL] [Abstract][Full Text] [Related]
8. Cardiac transplantation from non-viremic hepatitis C donors.
Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
[TBL] [Abstract][Full Text] [Related]
9. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
[TBL] [Abstract][Full Text] [Related]
10. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
[TBL] [Abstract][Full Text] [Related]
11. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
13. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
[TBL] [Abstract][Full Text] [Related]
15. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
16. Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
Suryaprasad A; Basavaraju SV; Hocevar SN; Theodoropoulos N; Zuckerman RA; Hayden T; Forbi JC; Pegues D; Levine M; Martin SI; Kuehnert MJ; Blumberg EA;
Am J Transplant; 2015 Jul; 15(7):1827-35. PubMed ID: 25943299
[TBL] [Abstract][Full Text] [Related]
17. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
Mooney JJ; Purington N; Mohabir P; Dhillon GS
Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
[TBL] [Abstract][Full Text] [Related]
19. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
Kling CE; Limaye AP; Landis CS; Sibulesky L
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
[TBL] [Abstract][Full Text] [Related]
20. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
Hannan HA; Goldberg DS
J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
